New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why

New Covid vaccines are coming to the U.S. this fall — but many Americans may not take them.
Pfizer, Moderna and Novavax are slated to deliver new single-strain coronavirus shots targeting the omicron subvariant XBB.1.5 in September.
Experts told CNBC that public health officials and providers could potentially increase uptake of the shots by communicating that they will likely become a routine part of health care moving forward.